Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129044) titled 'Impact of Intensive Lipid-Lowering Therapy with PCSK9 Inhibitors and Statin on Short-Term Outcomes in Symptomatic Intracranial/Extracranial Atherosclerotic Stenosis' on July 29.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Xi'an Jiaotong University Second Affiliated Hospital
Condition:
Ischemic stroke
Intervention:
PCSK9i + statin combination therapy group:On the basis of the same statin therapy with or without ezetimibe, add subcutaneous injection of PCSK9 inhibitor evolocumab
Statin monotherapy group:Receive moderate-intensity statin monotherapy (atorvastatin calcium tablets 20...